[
  {
    "text": "Confidential",
    "bbox": [
      1000,
      81,
      1000,
      93
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Execution Version",
    "bbox": [
      1000,
      98,
      1000,
      109
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "LICENSE AND DEVELOPMENT AGREEMENT",
    "bbox": [
      434,
      116,
      897,
      127
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "This LICENSE AND DEVELOPMENT AGREEMENT (this Agreement) is entered into effective as of Nov. 02, 2019",
    "bbox": [
      195,
      148,
      1000,
      162
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "(the Effective Date) by and between Bioeg IP AG, having its place of business at [***] (Bioeq) and Coherus BioSciences, Inc.,",
    "bbox": [
      114,
      168,
      1000,
      181
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "having its principal place of business at 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065, USA (Licensee).",
    "bbox": [
      112,
      186,
      1000,
      200
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Bioeq and Licensee shall also each individually be referred to herein as a Party, and shall be referred to jointly as the.",
    "bbox": [
      195,
      219,
      1000,
      233
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Parties.",
    "bbox": [
      109,
      237,
      180,
      253
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "RECITALS",
    "bbox": [
      612,
      272,
      720,
      284
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "WHEREAS, Bioeq is a specialized biosimilar company;.",
    "bbox": [
      196,
      302,
      653,
      318
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "WHEREAS, Bioeq is the owner or exclusive licensee of all right, title and interest to certain products which are being",
    "bbox": [
      195,
      335,
      1000,
      351
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "developed as biosimilars to pharmaceutical products comprising the monoclonal antibody fragment Ranibizumab and currently",
    "bbox": [
      114,
      355,
      1000,
      367
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "marketed in the field of ophthalmology under the brand name Lucentis;",
    "bbox": [
      111,
      372,
      713,
      387
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "WHEREAS, Licensee is a company focused on the development and commercialization of biosimilar products; and.",
    "bbox": [
      197,
      406,
      1000,
      418
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "WHEREAS, Licensee wishes to obtain an exclusive license from Bioeq for the commercialization of Ranibizumab.",
    "bbox": [
      196,
      437,
      1000,
      450
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "payments to Bioeq, and Bioeq is willing to grant such license subject to the terms and conditions of this Agreement..",
    "bbox": [
      111,
      473,
      1000,
      488
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants set forth below, the Parties.",
    "bbox": [
      192,
      505,
      1000,
      521
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      525,
      314,
      538
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1.DEFINITIONS AND INTERPRETATION",
    "bbox": [
      195,
      558,
      603,
      570
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "For purposes of this Agreement, the capitalized terms used in this Agreement shall have the respective meanings set forth in this",
    "bbox": [
      112,
      591,
      1000,
      604
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Section 1 below..",
    "bbox": [
      111,
      607,
      247,
      621
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1.1",
    "bbox": [
      193,
      640,
      225,
      655
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Affiliate means with respect to any Party, (a) any legal entity of which the securities or other ownership.",
    "bbox": [
      291,
      641,
      1000,
      655
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "interests representing more than 50% of the equity or more than 50% of the ordinary voting power or more than 50% of the general",
    "bbox": [
      111,
      659,
      1000,
      673
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "partnership interest are, at the time such determination is being made, owned, controlled or held, directly or indirectly, by such legal.",
    "bbox": [
      110,
      677,
      1000,
      692
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "entity; or (b) any legal entity which, at the time such determination is being made, is controlling or under common control with, such",
    "bbox": [
      112,
      695,
      1000,
      709
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Party. As used in this definition, the term \"control', whether used as a noun or verb, refers to the possession, directly or indirectly, of",
    "bbox": [
      113,
      714,
      1000,
      726
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "the power to direct, or cause the direction of, the management or policies of a legal entity, whether through the ownership of voting",
    "bbox": [
      111,
      731,
      1000,
      746
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "securities, by contract or otherwise.",
    "bbox": [
      112,
      750,
      406,
      762
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1.2",
    "bbox": [
      193,
      782,
      225,
      796
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Agreement shall have the meaning ascribed to it in the introductory paragraph above..",
    "bbox": [
      290,
      783,
      997,
      797
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1.3",
    "bbox": [
      192,
      816,
      226,
      831
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Applicable Law means any and all applicable federal, state, local and international laws, rules and regulations..",
    "bbox": [
      290,
      818,
      1000,
      831
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "including regulations of competent Regulatory Authorities and environmental laws, as amended from time to time, and the regulations.",
    "bbox": [
      113,
      835,
      1000,
      849
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "promulgated thereunder, as amended from time to time..",
    "bbox": [
      113,
      853,
      567,
      867
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "1.4",
    "bbox": [
      192,
      884,
      227,
      900
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "[***]",
    "bbox": [
      287,
      883,
      342,
      902
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Source: COHERUS BIOSCIENCES, INC., 10-K, 2/27/2020",
    "bbox": [
      133,
      1000,
      580,
      1000
    ],
    "label": 8,
    "category": "Governing Law"
  },
  {
    "text": "Confidential",
    "bbox": [
      1000,
      81,
      1000,
      93
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Execution Version",
    "bbox": [
      1000,
      98,
      1000,
      109
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "LICENSE AND DEVELOPMENT AGREEMENT",
    "bbox": [
      434,
      116,
      897,
      127
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "This LICENSE AND DEVELOPMENT AGREEMENT (this Agreement) is entered into effective as of Nov. 02, 2019",
    "bbox": [
      195,
      148,
      1000,
      162
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "(the Effective Date) by and between Bioeg IP AG, having its place of business at [***] (Bioeq) and Coherus BioSciences, Inc.,",
    "bbox": [
      114,
      168,
      1000,
      181
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "having its principal place of business at 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065, USA (Licensee).",
    "bbox": [
      112,
      186,
      1000,
      200
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Bioeq and Licensee shall also each individually be referred to herein as a Party, and shall be referred to jointly as the.",
    "bbox": [
      195,
      219,
      1000,
      233
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Parties.",
    "bbox": [
      109,
      237,
      180,
      253
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "RECITALS",
    "bbox": [
      612,
      272,
      720,
      284
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "WHEREAS, Bioeq is a specialized biosimilar company;.",
    "bbox": [
      196,
      302,
      653,
      318
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "WHEREAS, Bioeq is the owner or exclusive licensee of all right, title and interest to certain products which are being",
    "bbox": [
      195,
      335,
      1000,
      351
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "developed as biosimilars to pharmaceutical products comprising the monoclonal antibody fragment Ranibizumab and currently",
    "bbox": [
      114,
      355,
      1000,
      367
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "marketed in the field of ophthalmology under the brand name Lucentis;",
    "bbox": [
      111,
      372,
      713,
      387
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "WHEREAS, Licensee is a company focused on the development and commercialization of biosimilar products; and.",
    "bbox": [
      197,
      406,
      1000,
      418
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "WHEREAS, Licensee wishes to obtain an exclusive license from Bioeq for the commercialization of Ranibizumab.",
    "bbox": [
      196,
      437,
      1000,
      450
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "payments to Bioeq, and Bioeq is willing to grant such license subject to the terms and conditions of this Agreement..",
    "bbox": [
      111,
      473,
      1000,
      488
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants set forth below, the Parties.",
    "bbox": [
      192,
      505,
      1000,
      521
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      525,
      314,
      538
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.DEFINITIONS AND INTERPRETATION",
    "bbox": [
      195,
      558,
      603,
      570
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "For purposes of this Agreement, the capitalized terms used in this Agreement shall have the respective meanings set forth in this",
    "bbox": [
      112,
      591,
      1000,
      604
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Section 1 below..",
    "bbox": [
      111,
      607,
      247,
      621
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.1",
    "bbox": [
      193,
      640,
      225,
      655
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Affiliate means with respect to any Party, (a) any legal entity of which the securities or other ownership.",
    "bbox": [
      291,
      641,
      1000,
      655
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "interests representing more than 50% of the equity or more than 50% of the ordinary voting power or more than 50% of the general",
    "bbox": [
      111,
      659,
      1000,
      673
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "partnership interest are, at the time such determination is being made, owned, controlled or held, directly or indirectly, by such legal.",
    "bbox": [
      110,
      677,
      1000,
      692
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "entity; or (b) any legal entity which, at the time such determination is being made, is controlling or under common control with, such",
    "bbox": [
      112,
      695,
      1000,
      709
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Party. As used in this definition, the term \"control', whether used as a noun or verb, refers to the possession, directly or indirectly, of",
    "bbox": [
      113,
      714,
      1000,
      726
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "the power to direct, or cause the direction of, the management or policies of a legal entity, whether through the ownership of voting",
    "bbox": [
      111,
      731,
      1000,
      746
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "securities, by contract or otherwise.",
    "bbox": [
      112,
      750,
      406,
      762
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.2",
    "bbox": [
      193,
      782,
      225,
      796
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Agreement shall have the meaning ascribed to it in the introductory paragraph above..",
    "bbox": [
      290,
      783,
      997,
      797
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.3",
    "bbox": [
      192,
      816,
      226,
      831
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Applicable Law means any and all applicable federal, state, local and international laws, rules and regulations..",
    "bbox": [
      290,
      818,
      1000,
      831
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "including regulations of competent Regulatory Authorities and environmental laws, as amended from time to time, and the regulations.",
    "bbox": [
      113,
      835,
      1000,
      849
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "promulgated thereunder, as amended from time to time..",
    "bbox": [
      113,
      853,
      567,
      867
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "1.4",
    "bbox": [
      192,
      884,
      227,
      900
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "[***]",
    "bbox": [
      287,
      883,
      342,
      902
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Source: COHERUS BIOSCIENCES, INC., 10-K, 2/27/2020",
    "bbox": [
      133,
      1000,
      580,
      1000
    ],
    "label": 21,
    "category": "Minimum Commitment"
  },
  {
    "text": "Confidential",
    "bbox": [
      1000,
      81,
      1000,
      93
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Execution Version",
    "bbox": [
      1000,
      98,
      1000,
      109
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "LICENSE AND DEVELOPMENT AGREEMENT",
    "bbox": [
      434,
      116,
      897,
      127
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "This LICENSE AND DEVELOPMENT AGREEMENT (this Agreement) is entered into effective as of Nov. 02, 2019",
    "bbox": [
      195,
      148,
      1000,
      162
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "(the Effective Date) by and between Bioeg IP AG, having its place of business at [***] (Bioeq) and Coherus BioSciences, Inc.,",
    "bbox": [
      114,
      168,
      1000,
      181
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "having its principal place of business at 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065, USA (Licensee).",
    "bbox": [
      112,
      186,
      1000,
      200
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Bioeq and Licensee shall also each individually be referred to herein as a Party, and shall be referred to jointly as the.",
    "bbox": [
      195,
      219,
      1000,
      233
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Parties.",
    "bbox": [
      109,
      237,
      180,
      253
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "RECITALS",
    "bbox": [
      612,
      272,
      720,
      284
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS, Bioeq is a specialized biosimilar company;.",
    "bbox": [
      196,
      302,
      653,
      318
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS, Bioeq is the owner or exclusive licensee of all right, title and interest to certain products which are being",
    "bbox": [
      195,
      335,
      1000,
      351
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "developed as biosimilars to pharmaceutical products comprising the monoclonal antibody fragment Ranibizumab and currently",
    "bbox": [
      114,
      355,
      1000,
      367
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "marketed in the field of ophthalmology under the brand name Lucentis;",
    "bbox": [
      111,
      372,
      713,
      387
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS, Licensee is a company focused on the development and commercialization of biosimilar products; and.",
    "bbox": [
      197,
      406,
      1000,
      418
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS, Licensee wishes to obtain an exclusive license from Bioeq for the commercialization of Ranibizumab.",
    "bbox": [
      196,
      437,
      1000,
      450
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "payments to Bioeq, and Bioeq is willing to grant such license subject to the terms and conditions of this Agreement..",
    "bbox": [
      111,
      473,
      1000,
      488
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants set forth below, the Parties.",
    "bbox": [
      192,
      505,
      1000,
      521
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      525,
      314,
      538
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.DEFINITIONS AND INTERPRETATION",
    "bbox": [
      195,
      558,
      603,
      570
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "For purposes of this Agreement, the capitalized terms used in this Agreement shall have the respective meanings set forth in this",
    "bbox": [
      112,
      591,
      1000,
      604
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Section 1 below..",
    "bbox": [
      111,
      607,
      247,
      621
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.1",
    "bbox": [
      193,
      640,
      225,
      655
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Affiliate means with respect to any Party, (a) any legal entity of which the securities or other ownership.",
    "bbox": [
      291,
      641,
      1000,
      655
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "interests representing more than 50% of the equity or more than 50% of the ordinary voting power or more than 50% of the general",
    "bbox": [
      111,
      659,
      1000,
      673
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "partnership interest are, at the time such determination is being made, owned, controlled or held, directly or indirectly, by such legal.",
    "bbox": [
      110,
      677,
      1000,
      692
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "entity; or (b) any legal entity which, at the time such determination is being made, is controlling or under common control with, such",
    "bbox": [
      112,
      695,
      1000,
      709
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Party. As used in this definition, the term \"control', whether used as a noun or verb, refers to the possession, directly or indirectly, of",
    "bbox": [
      113,
      714,
      1000,
      726
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "the power to direct, or cause the direction of, the management or policies of a legal entity, whether through the ownership of voting",
    "bbox": [
      111,
      731,
      1000,
      746
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "securities, by contract or otherwise.",
    "bbox": [
      112,
      750,
      406,
      762
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.2",
    "bbox": [
      193,
      782,
      225,
      796
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Agreement shall have the meaning ascribed to it in the introductory paragraph above..",
    "bbox": [
      290,
      783,
      997,
      797
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.3",
    "bbox": [
      192,
      816,
      226,
      831
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Applicable Law means any and all applicable federal, state, local and international laws, rules and regulations..",
    "bbox": [
      290,
      818,
      1000,
      831
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "including regulations of competent Regulatory Authorities and environmental laws, as amended from time to time, and the regulations.",
    "bbox": [
      113,
      835,
      1000,
      849
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "promulgated thereunder, as amended from time to time..",
    "bbox": [
      113,
      853,
      567,
      867
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.4",
    "bbox": [
      192,
      884,
      227,
      900
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "[***]",
    "bbox": [
      287,
      883,
      342,
      902
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Source: COHERUS BIOSCIENCES, INC., 10-K, 2/27/2020",
    "bbox": [
      133,
      1000,
      580,
      1000
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Confidential",
    "bbox": [
      1000,
      81,
      1000,
      93
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Execution Version",
    "bbox": [
      1000,
      98,
      1000,
      109
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "LICENSE AND DEVELOPMENT AGREEMENT",
    "bbox": [
      434,
      116,
      897,
      127
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "This LICENSE AND DEVELOPMENT AGREEMENT (this Agreement) is entered into effective as of Nov. 02, 2019",
    "bbox": [
      195,
      148,
      1000,
      162
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "(the Effective Date) by and between Bioeg IP AG, having its place of business at [***] (Bioeq) and Coherus BioSciences, Inc.,",
    "bbox": [
      114,
      168,
      1000,
      181
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "having its principal place of business at 333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065, USA (Licensee).",
    "bbox": [
      112,
      186,
      1000,
      200
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Bioeq and Licensee shall also each individually be referred to herein as a Party, and shall be referred to jointly as the.",
    "bbox": [
      195,
      219,
      1000,
      233
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Parties.",
    "bbox": [
      109,
      237,
      180,
      253
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "RECITALS",
    "bbox": [
      612,
      272,
      720,
      284
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "WHEREAS, Bioeq is a specialized biosimilar company;.",
    "bbox": [
      196,
      302,
      653,
      318
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "WHEREAS, Bioeq is the owner or exclusive licensee of all right, title and interest to certain products which are being",
    "bbox": [
      195,
      335,
      1000,
      351
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "developed as biosimilars to pharmaceutical products comprising the monoclonal antibody fragment Ranibizumab and currently",
    "bbox": [
      114,
      355,
      1000,
      367
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "marketed in the field of ophthalmology under the brand name Lucentis;",
    "bbox": [
      111,
      372,
      713,
      387
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "WHEREAS, Licensee is a company focused on the development and commercialization of biosimilar products; and.",
    "bbox": [
      197,
      406,
      1000,
      418
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "WHEREAS, Licensee wishes to obtain an exclusive license from Bioeq for the commercialization of Ranibizumab.",
    "bbox": [
      196,
      437,
      1000,
      450
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "payments to Bioeq, and Bioeq is willing to grant such license subject to the terms and conditions of this Agreement..",
    "bbox": [
      111,
      473,
      1000,
      488
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants set forth below, the Parties.",
    "bbox": [
      192,
      505,
      1000,
      521
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "hereby agree as follows:.",
    "bbox": [
      113,
      525,
      314,
      538
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.DEFINITIONS AND INTERPRETATION",
    "bbox": [
      195,
      558,
      603,
      570
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "For purposes of this Agreement, the capitalized terms used in this Agreement shall have the respective meanings set forth in this",
    "bbox": [
      112,
      591,
      1000,
      604
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Section 1 below..",
    "bbox": [
      111,
      607,
      247,
      621
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.1",
    "bbox": [
      193,
      640,
      225,
      655
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Affiliate means with respect to any Party, (a) any legal entity of which the securities or other ownership.",
    "bbox": [
      291,
      641,
      1000,
      655
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "interests representing more than 50% of the equity or more than 50% of the ordinary voting power or more than 50% of the general",
    "bbox": [
      111,
      659,
      1000,
      673
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "partnership interest are, at the time such determination is being made, owned, controlled or held, directly or indirectly, by such legal.",
    "bbox": [
      110,
      677,
      1000,
      692
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "entity; or (b) any legal entity which, at the time such determination is being made, is controlling or under common control with, such",
    "bbox": [
      112,
      695,
      1000,
      709
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Party. As used in this definition, the term \"control', whether used as a noun or verb, refers to the possession, directly or indirectly, of",
    "bbox": [
      113,
      714,
      1000,
      726
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "the power to direct, or cause the direction of, the management or policies of a legal entity, whether through the ownership of voting",
    "bbox": [
      111,
      731,
      1000,
      746
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "securities, by contract or otherwise.",
    "bbox": [
      112,
      750,
      406,
      762
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.2",
    "bbox": [
      193,
      782,
      225,
      796
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Agreement shall have the meaning ascribed to it in the introductory paragraph above..",
    "bbox": [
      290,
      783,
      997,
      797
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.3",
    "bbox": [
      192,
      816,
      226,
      831
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Applicable Law means any and all applicable federal, state, local and international laws, rules and regulations..",
    "bbox": [
      290,
      818,
      1000,
      831
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "including regulations of competent Regulatory Authorities and environmental laws, as amended from time to time, and the regulations.",
    "bbox": [
      113,
      835,
      1000,
      849
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "promulgated thereunder, as amended from time to time..",
    "bbox": [
      113,
      853,
      567,
      867
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "1.4",
    "bbox": [
      192,
      884,
      227,
      900
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "[***]",
    "bbox": [
      287,
      883,
      342,
      902
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  },
  {
    "text": "Source: COHERUS BIOSCIENCES, INC., 10-K, 2/27/2020",
    "bbox": [
      133,
      1000,
      580,
      1000
    ],
    "label": 30,
    "category": "Irrevocable Or Perpetual License"
  }
]